跳至主要内容
临床试验/NCT01082172
NCT01082172已完成不适用

A Pilot Trial to Evaluate the Performance of the TriVascular Thoracic Stent Graft System

TriVascular, Inc.1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2
试验地点
1
主要终点
Absence of device-related serious adverse events within 30-days of endovascular procedure

研究概览

简要总结

A prospective, non-randomized multi-center clinical evaluation of the performance of the TriVascular Thoracic Stent Graft System when used in the treatment of subjects with thoracic aortic aneurysms (TAA).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The TriVascular Thoracic Stent Graft System is indicated in subjects diagnosed with an aneurysm in the descending thoracic aorta having vascular morphology suitable for endovascular repair, including:
  • Adequate iliac/femoral access compatible with the required delivery systems,
  • Non-aneurysmal aortic segments proximal and distal to the aneurysm.

排除标准

  • 未提供

结局指标

主要结局

Absence of device-related serious adverse events within 30-days of endovascular procedure

时间窗: 30-Days

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验